What Are Wall Street Analysts’ Target Price for Edwards Lifesciences Stock?

Valued at a market cap of $45.7 billion, Edwards Lifesciences Corporation (EW) provides products and technologies to treat advanced cardiovascular diseases. The Irvine, California-based company is known for its patient-centric approach and close collaboration with physicians. This healthcare company has underperformed the broader market over the past 52 weeks. Shares of EW have gained 10.9% over this […]